Search for: "Sanofi S A"
Results 41 - 60
of 933
Sort by Relevance
|
Sort by Date
14 Dec 2023, 10:00 pm
August: In Nigeria, the French multinational pharmaceutical and healthcare company Sanofi S.A., filed a petition with the Corporate Affairs Commission (CAC) in 2019, alleging that the registration of Sanofi Integrated Services Limited, Sanofi Nigeria Enterprises Limited, and Sanofi Nigerian Enterprise was unlawful. [read post]
14 Dec 2023, 12:15 pm
Sanofi decisions, respectively. [read post]
14 Dec 2023, 12:15 pm
Sanofi decisions, respectively. [read post]
13 Dec 2023, 1:29 am
The appeal case T 1356/21 related to the novelty of Sanofi's patent (EP2571517). [read post]
8 Dec 2023, 7:58 am
Sanofi is an important case, but it won’t transform patent law on its own. [read post]
7 Dec 2023, 11:17 am
This appointment positions Buchanan at the forefront of a critical legal battle against insulin manufacturers Eli Lilly, Novo Nordisk, and Sanofi – who control nearly the entire U.S. insulin market – as well as the nation’s three largest pharmacy benefit managers (PBMs), CVS Caremark, Express Scripts, and OptumRx, over allegations these companies used unlawful, unfair, and deceptive practices to aggressively hike the cost of insulin and other diabetes medications.… [read post]
7 Dec 2023, 6:00 am
Mary’s County, MD; and Henrico County, VA. [read post]
4 Dec 2023, 10:00 pm
Sanofi , 143 S. [read post]
3 Dec 2023, 9:15 am
Sanofi 598 U.S. 594 (2023) will be one of the most significant, if not the most significant Supreme Court patent decision of 2023. [read post]
3 Dec 2023, 9:15 am
Sanofi 598 U.S. 594 (2023) will be one of the most significant, if not the most significant Supreme Court patent decision of 2023. [read post]
29 Nov 2023, 8:41 am
Click-To-Call Techs., LP, 140 S. [read post]
24 Nov 2023, 6:08 pm
Greene’s Energy Group, LLC, 138 S. [read post]
22 Nov 2023, 3:41 am
Sanofi, the 2023 Supreme Court invalidated Amgen’s broad functional genus claim covering for monoclonal antibodies that bind to PCSK9 to lower cholesterol. [read post]
17 Nov 2023, 6:00 am
The Amgen and Sanofi dispute is another case where proceedings are pending in multiple UPC fora, this time before the Central Division (Pari [read post]
14 Nov 2023, 9:10 am
One of the nation’s preeminent plaintiffs’ law firms, Seeger Weiss is best known for multidistrict mass torts and class actions in both state and federal court—and especially for taking those cases to trial. [read post]
19 Oct 2023, 6:22 am
The courts below rejected Sanofi’s request for extending the time limits, because most of the annexes were already available to Sanofi. [read post]
18 Oct 2023, 4:58 pm
Sanofi, the Supreme Court stated that “the specification much enable the full scope of the invention as defined by its claims,” allowing for “a reasonable amount of experimentation. [read post]
9 Oct 2023, 10:45 pm
With the central case law and regulatory updates, this event focuses on the European market and those working within life science IP.As the agenda also indicates, the following promise to be the highlights of this year’s edition:Form a holistic and practical UPC litigation strategy with a cross-industry case law review, a mock trial alongside leading judges and litigators and a pharma and biotech UPC strategy panel.Update one’s own pharma and biotech patent litigation… [read post]
4 Oct 2023, 5:27 pm
Sanofi, 143 S. [read post]
4 Oct 2023, 12:19 pm
Sanofi decision for both biotech and “regular” tech. [read post]
